Stay updated with breaking news from Targeted Hyperthermia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sona Nanotech Inc. is pleased to advise that it has appointed Dr. Carman Giacomantonio MD, MSc., FRCSC to be the Company's Chief Medical Officer. Dr. Giacomantonio is a practicing Surgical...
Sona Nanotech Inc. announces further results from the triple negative breast cancer murine model portion of its current research study at Dalhousie University which confirms that the previously...
Sona Nanotech Inc. announces that it has been approved for funding totaling approximately $40,000 to support the development of its intellectual property portfolio. The Company is receiving...
Sona Nanotech Inc. announces positive interim results from its study with The Giacomantonio Immuno-Oncology Research Group at Dalhousie University . An update received by the Company indicates...
Sona Nanotech Inc. announces that Dr. Michael Gross has retired from the Company's Board of Directors to focus on other business interests. Mike has been a valuable member of Sona's Board, and we...